In another great article, Evelyn Pringle writes about Paxil Birth Defect Litigation – Battle of the Decade.
Just over a year ago, the FDA reclassified Paxil (Seroxat) from a Category C drug to a Category D for pregnant women. Category C is for drugs that have been shown to harm the fetus in animals. Category D means a drug has been found to harm the human fetus.
In a December 1, 2006 news release, the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, advised that Paxil should be avoided “by pregnant women or women planning to become pregnant due to the potential risk of fetal heart defects, newborn persistent pulmonary hypertension, and other negative effects.”
An interesting comment in the announcement states: “Unpublished data regarding the use of Paxil during the first trimester of pregnancy have raised concerns about an increased risk of congenital heart malformations.”
This discussion begs the question of exactly how much more “unpublished data” is out there about the dangers of Paxil that the public will hear about later, rather than sooner.
Please go and read Evelyn’s great (as ever) article – the link is at the top of this post.
Thanks also to Mouse at Paxil Progress and Truthman30 for reminding me about this horrible aspect of Seroxat.